Search

Background: Index case HIV/AIDS testing (ICHT) is a good approach for addressing and improving the efficiency and yield of testing among high-risk populations. Partners and families of people living with HIV/AIDS are among the high-risk populations for contracting HIV/AIDS. However, there is limited study on index case HIV testing among HIV patients attending Anti-Retroviral Therapy (ART). Hence, this study was aimed at assessing the magnitude and factors associated with ICHT among HIV patients attending ART in Nekemte town public health facilities. Methods: An institution-based cross-sectional study was conducted at Nekemte town public health facilities from May 20 to July 21, 2020. A systematic random sampling method was used to select the study participants. Multivariable logistic regression analysis was used to determine the predictors of acceptance of ICHT among HIV patients. Results: The ICHT acceptance was 85.2% (95% CI=84.9– 91.1%). Disclosure of their HIV status (AOR=9.74, 95% CI=4.11– 23.06), having good knowledge of ICHT (AOR=4.70, 95% CI=1.92– 11.61), believing HIV index case testing has benefits (AOR=3.43, 95% CI=1.27– 9.29), and being on ART for more than 1 year (AOR=4.78, 95% CI=2.13– 10.76) were significantly associated with index case HIV test acceptance. Conclusion and Recommendation: This study revealed a significant proportion of index case HIV testing acceptance. HIV status disclosure of index cases, knowledge of ICHT, the perceived benefit of ICHT, and long duration on ART were found to be significantly associated with acceptance of ICHT. Hence, it is essential to give attention to counseling on the importance of ICHT, enhance people living with HIV (PLWHIV) to have positive belief on the advantage of ICHT, strengthen disclosure counseling, and assist HIV status disclosure in health facilities. [ABSTRACT FROM AUTHOR]

Background: Poor family and social support is a problem for patients taking antiretroviral therapy (ART), but it protects them against the negative consequences of stress, reducing morbidity and mortality among peoples living with human immunodeficiency virus (PLWHIV). Objective: This study aimed to assess family and social support and the associated factors among patients on antiretroviral therapy in West Wollega Public Hospitals. Methods: A facility-based cross-sectional study design was conducted among 329 respondents attending antiretroviral therapy (ARV) clinics in West Wollega Public Hospitals from September 1– 30, 2020. Data were collected by simple random sampling methods using an interviewer-administered questionnaire. Bivariate and multivariate logistic regression analysis was used. The strength and presence of statistical association were assessed using adjusted odds ratio with a 95% confidence interval. Results: About 266 (66.4%) of the respondents had low family and social support. Being female sex [AOR (95% CI)=0.066 (0.013– 0.338)], failing to discuss with family or society [AOR (95% CI)=0.275 (0.100– 0.753)], lack of information on support [AOR (95% CI)=0.314 (0.104– 0.951)], and non-disclosure of HIV status to family [AOR (95% CI)=0.227 (0.084– 0.916)] were associated with family and social support. Conclusion: In this study, family and social support to people living with HIV/AIDS is low. Being female sex, feelings of negative treatment, lack of discussion on support, lack of information about support, and failure to disclose HIV status were associated with low family and social support. Information, education, and communication should be intensified to increase the awareness of the community, family, and people living with HIV related to support for people living with HIV. [ABSTRACT FROM AUTHOR]